(13BS)-5,16-dimethoxy-4,17-dihydro-2H-cyclopenta[6,7]cycloocta[2,1-a:3,4-a']dinaphthalene

Catalog No. :
ACRQYH027
CAS No. :
2243644-97-3
Molecular Formula :
C29H24O2
Molecular Weight :
404.51

IUPAC Name:5,16-dimethoxy-4,17-dihydro-2H-cyclopenta[6,7]cycloocta[2,1-a:3,4-a']dinaphthalene

(13BS)-5,16-dimethoxy-4,17-dihydro-2H-cyclopenta[6,7]cycloocta[2,1-a:3,4-a']dinaphthalene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(13BS)-5,16-dimethoxy-4,17-dihydro-2H-cyclopenta[6,7]cycloocta[2,1-a:3,4-a']dinaphthalene
IUPAC Name5,16-dimethoxy-4,17-dihydro-2H-cyclopenta[6,7]cycloocta[2,1-a:3,4-a']dinaphthalene
MDL No.-
Molecular FormulaC29H24O2
Molecular Weight404.51
SMILESCOC1=CC2=C(C=CC=C2)C3=C1CC4=CCC=C4CC5=C3C6=C(C=CC=C6)C=C5OC
InChI KeyOIUQJKIPFMAVJU-UHFFFAOYSA-N
Synonym(13BS)-5,16-dimethoxy-4,17-dihydro-2H-cyclopenta[6,7]cycloocta[2,1-a:3,4-a']dinaphthalene
CAS No.2243644-97-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACRQYH027 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRQYH027 route product structure diagram
    ACRQYH0272243644-97-3
Inquiry

2. ACRQYH027 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRQYH027 route product structure diagram
    ACRQYH0272243644-97-3
Inquiry

Comments (0)